Ling-Heng Kong - Concepedia

Author

Ling-Heng Kong

Sun Yat-sen University Cancer Center

Also Known As

Ling-Heng Kong, Ling-heng Kong, Lingheng Kong

Publications

1.4K

Citations

H-Index

Concepts

All Affiliations

Sun Yat-sen University Cancer Center Sun Yat-sen University State Key Laboratory of Oncology in South China Guangzhou Medical University Sixth Affiliated Hospital of Sun Yat-sen University

About

Ling-Heng Kong is an author at Sun Yat-sen University Cancer Center specializing in radiation oncology, medicine, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	304
2	Engineering	1	1	30
3	Health Sciences	1	1	30
4	Immunology	1	1	219
5	Obstetrics	1	1	16

Ling-Heng Kong

Publications

1.3K

Citations

H-Index

Page 1

	Year	Citations
Tumor-derived lactate promotes resistance to bevacizumab treatment by facilitating autophagy enhancer protein RUBCNL expression through histone H3 lysine 18 lactylation (H3K18la) in colorectal cancer Weihao Li, Chi Zhou, Long Yu, Autophagy	2023	330
Elevated preoperative neutrophil to lymphocyte ratio predicts risk of recurrence following curative resection for stage IIA colon cancer Pei-Rong Ding, Xin An, Rongxin Zhang, International Journal of Colorectal Disease Surgical OncologyGastrointestinal OncologyColorectal SurgeryCancer RecurrenceCurative Resection	2010	219
Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer Qiaoqi Sui, Xi Zhang, Chao Chen, Nature Communications	2022	141
Neoadjuvant Sandwich Treatment With Oxaliplatin and Capecitabine Administered Prior to, Concurrently With, and Following Radiation Therapy in Locally Advanced Rectal Cancer: A Prospective Phase 2 Trial Yuanhong Gao, Jun-Zhong Lin, Xin An, International Journal of Radiation OncologyBiologyPhysics Radiation MedicineRadiation TherapyGastrointestinal OncologyMedicineNeoadjuvant Sandwich Treatment	2014	58
Dickkopf 1 impairs the tumor response to PD-1 blockade by inactivating CD8+ T cells in deficient mismatch repair colorectal cancer Qiaoqi Sui, Dingxin Liu, Jiang Wu, Journal for ImmunoTherapy of Cancer	2021	56
PD-1 blockade in neoadjuvant setting of DNA mismatch repair-deficient/microsatellite instability-high colorectal cancer Ding-Xin Liu, Dandan Li, Wan He, OncoImmunology	2020	47
Neoadjuvant Immunotherapy Leads to Major Response and Low Recurrence in Localized Mismatch Repair–Deficient Colorectal Cancer Binyi Xiao, Xuan Zhang, Taiyuan Cao, Journal of the National Comprehensive Cancer Network	2023	38
Anti-PD-1-based immunotherapy as curative-intent treatment in dMMR/MSI-H rectal cancer: A multicentre cohort study Qiaoxuan Wang, Binyi Xiao, Yong Cheng, European Journal of Cancer	2022	36
Neoadjuvant Immune Checkpoint Inhibition Improves Organ Preservation in T4bM0 Colorectal Cancer With Mismatch Repair Deficiency: A Retrospective Observational Study Kai Han, Jinghua Tang, Leen Liao, Diseases of the Colon & Rectum	2022	32
Simple measurements on diffusion-weighted MR imaging for assessment of complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer Pei‐Qiang Cai, Yao-Pan Wu, Xin An, European Radiology EngineeringMedical ImagingSimple MeasurementsDiffusion-weighted Mr ImagingBiomedical Imaging	2014	30

Page 1